You are here
Home > Business > Health Care > Newborn Screening Market 2018 Segmentation : Product Type, Test Type, End-users, Geography, Growth, Trends, and Forecast 2023

Newborn Screening Market 2018 Segmentation : Product Type, Test Type, End-users, Geography, Growth, Trends, and Forecast 2023

The Newborn Screening Market is expected to register a CAGR of 9.0% during the forecast period, 2018 to 2023. North America dominates the market, due to growing awareness regarding newborn screening in the region.

Request Sample PDF @  http://orbisresearch.com/contacts/request-sample/2131975

Technological Advancements

The rapid pace of developments in the field of expanded newborn screening has been made possible through technological advancement in the devices and kits. This enables the detection of multiple compounds in the diagnosis of diverse inborn errors of metabolism in the neonatal dried blood specimens. After the success of newborn screening in phenylketonuria, major competitors in this field have continued to develop and introduce new models with significant performance improvements, which is likely to drive the market. Additionally, growing newborn screening programs worldwide, rising incidences of congenital diseases, and rising funding from government sectors are likely to surge the market growth of Newborn Screening Market globally.

False Positives & False Negatives

Newborn screening tests are only the screening tests and not confirmatory tests. According to a survey, screening tests can have a higher margin of error and be less valid than diagnostic tests, but they should have a very low false negative rate. It is estimated that, on the expanded newborn screening panel, only about one in fifty of every positive new-born screening test detects actual disease. It is also noted that the average rate of false positives can vary widely, and it depends on the conditions tested. One in ten positive tests for cystic fibrosis is a true positive result, while one in 100 or one in 200 positive tests for congenital adrenal hyperplasia is a true positive result. The unreliability of few newborn screening tests and lack of uniformity of newborn screening policies and procedures, across the globe, is likely to impede the growth of the market.

North America to Dominate the Newborn Screening Market

North America is expected to hold the largest share of the Newborn Screening Market during the forecast period, due to growing awareness regarding newborn screening tests. For instance, in the United States, over 4,000,000 screenings are performed annually.

In the United States, both federal and state governments make policies governing newborn screening, which is augmenting the demand for newborn screening tests in the region.

Newborn Screening Market report focuses on the top players like;

  • AB SCIEX PTE LTD,
  • AGILENT TECHNOLOGIES,
  • BIO-RAD LABORATORIES, INC.,
  • GE HEALTHCARE,
  • MASIMO CORPORATION,
  • MEDTRONIC,
  • NATUS MEDICAL
  • INCORPORATED,
  • PERKINELMER, INC.,
  • TRIVITRON HEALTHCARE, AND
  • ZENTECH

Make an Enquiry  @ http://orbisresearch.com/contacts/enquiry-before-buying/2131975

Every region’s market analysis has been covered in the Newborn Screening Market report including the region’s ranking in terms of revenues, volume, growth rate, leading applications and types of the product, and the major drivers and constraints for the specific regions.

Segment by Regions/Countries, report covers:

  • North America
  • Europe
  • Asia-Pacific
  • Middle East & Africa
  • South America

 

The global Newborn Screening Market report covers a detailed analysis of the performance of each type in the market globally as well as across all regions and presents the customers with an absolute overview of the Newborn Screening Market in terms of the types as to which is the best bet for the customer to invest upon.

Key Developments in the Newborn Screening Market;

  • February 2018: Masimo Corporation received CE marking of Eve™, a Critical Congenital Heart Disease (CCHD) newborn screening application, for the Rad-97™ Pulse CO-Oximeter.
  • February 2017: The US Food and Drug Administration (FDA) permitted marketing of the Seeker System for the screening of four, rare Lysosomal Storage Disorders (LSDs) in newborns.

Segment by Type, Newborn Screening Market can be split into:

  • Device
  • Assay Kits

Reasons to Purchase the Newborn Screening Market Report ;

  • Current and future global Newborn Screening Market outlook in the developed and emerging markets
  • Analysis of various perspectives of the market with the help of Porter’s five forces analysis
  • The segment that is expected to dominate the market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, market shares, and strategies employed by the major market players
  • 3-month analyst support, along with the Market Estimate sheet (in Excel)

Browse Full Report @ http://orbisresearch.com/reports/index/global-newborn-screening-market-segmented-by-product-type-test-type-end-users-and-geography-growth-trends-and-forecast-2018-2023

About Us:

Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Information:
Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +9164101019
Email: sales@orbisresearch.com

Leave a Reply

Top